Mechanisms of Adverse Drug Effects in Children (R21)

The summary for the Mechanisms of Adverse Drug Effects in Children (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Mechanisms of Adverse Drug Effects in Children (R21)
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-06-352
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Apr 12, 2006
	Creation Date:	Apr 12, 2006
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Feb 02, 2008
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	$200,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities Independent school districts County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments Special district governments State governments
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. -Domestic Institutions -Faith-based or community-based organizations -Indian/Native American Tribal Government (Federally Recognized) -Indian/Native American Tribal Government (Other than Federally Recognized) -Indian/Native American Tribally Designated Organization.
Grant Description: - The major focus of the funding opportunity is to solicit projects that enhance the state-of-the-science on the molecular and cellular mechanisms involved in the production of adverse drug reactions in children.-Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.-The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.-This funding opportunity will utilize the exploratory/developmental (R21) grant mechanism and runs in parallel with an FOA of identical scientific scope (PA-05-045) that solicits applications under the traditional Research Project Grant (R01) award mechanism.-Eligible Organizations: For-profit and non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government; domestic or foreign institutions/organizations; faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization-Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-06-352.html http://grants.nih.gov/grants/guide/pa-files/PA-06-352.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION